Physician profile
Michael N Drucker
NPI 1780664128
$36,874.41
in general payments reported to CMS, 2019-2025
26 companies · $2,645 in 2025
The $2,645 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,297 · 2020: $6,387 · 2021: $6,949 · 2022: $7,208 · 2023: $5,541 · 2024: $848 · 2025: $2,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,757 · Travel and Lodging: $2,776 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,757.06 |
| Travel and Lodging | $2,776.38 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $22,970.15 | 2019-2024 | Remede System |
| Abbott Laboratories | $3,380.29 | 2019-2025 | Aveir, Assurity, Gallant |
| Medtronic, INC. | $2,087.85 | 2021-2025 | Micra, Pulseselect, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $2,062.52 | 2019-2025 | Watchman Access System, Watchman, Ingevity+ |
| Novartis Pharmaceuticals Corporation | $1,001.95 | 2019-2025 | |
| Cardiva Medical, INC. | $651.96 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire, Savvywire |
| Biotronik INC. | $584.48 | 2019-2025 | Acticor 7 Vr-T Dx, Biomonitor, Edora 8 Dr-T |
| Astrazeneca Pharmaceuticals LP | $573.77 | 2019-2023 | Wainua |
| E.R. Squibb & Sons, L.L.C. | $456.11 | 2019-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $448.91 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $412.33 | 2019-2022 | |
| Amgen INC. | $409.34 | 2019-2025 | Repatha |
| Biosense Webster, INC. | $385.13 | 2019-2025 | Smartablatetm System Rf Generator, Na, Nuvision Ice Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $336.51 | 2020-2023 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $326.42 | 2019-2025 | Lifevest |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $200.02 | 2022-2023 | Barostim Neo System |
| Atricure, INC. | $140.27 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Philips North America LLC | $133.28 | 2024 | (Ck4) Mcot, (Cm9) Amb Mon & Diag Und |
| Pfizer INC. | $87.62 | 2020-2022 | |
| Elutia, INC. | $76.50 | 2019-2024 | Ecm Patch,Pouch |
| Bayer Healthcare Pharmaceuticals INC. | $35.38 | 2023 | |
| Novo Nordisk INC | $33.92 | 2023-2024 | Rybelsus, Ozempic |
| Vital Connect, INC | $26.90 | 2023 | Vitalpatch Rtm |
| Otsuka America Pharmaceutical, INC. | $19.11 | 2019 | |
| Convatec INC. | $17.88 | 2022 | |
| Bridgebio Pharma, INC. | $15.81 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Drucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.